Open AccessQuadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons
Author(s) -
Ghassan Dbaibo,
Arshad Amanullah,
Carine Claeys,
Allen Izu,
Varsha Jain,
Pope Kosalaraksa,
Luis Rivera,
Jyoti Soni,
Emad Yanni,
Khalequ Zaman,
Beatriz Acosta,
Miguel Ariza,
Maria Basanta,
Ashish Bavdekar,
Alfonso Carmona,
Luis Cousin,
Jasur Danier,
Adolfo E Diaz,
Javier Díez-Domingo,
Ener Çağrı Dinleyici,
Saul N. Faust,
José García-Sicilia,
Grace Devota Gomez-Go,
Maria Gonzales,
Mustafa Hacımustafaoğlu,
Stephen Hughes,
Teresa Jackowska,
Shashi Kant,
Marilla Lucero,
Josep Marès Bermúdez,
Federico MartinónTorres,
May Montellano,
Roman Prymula,
Thanyawee Puthanakit,
Renata Růžková,
Iwona Sadowska-Krawczenko,
Henryk Szymański,
Àngels Ulied,
Wayne Woo,
Anne Schuind,
Bruce L. Innis
Publication year - 2020
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000002504
Subject(s) - health care , medicine , virology , intensive care medicine , influenza vaccine , vaccination , immunology , economics , economic growth
We evaluated an inactivated quadrivalent influenza vaccine (IIV4) in children 6-35 months of age in a phase III, observer-blind trial.